Showing Results for
From:PLoS ONE (Vol. 16, Issue 3) Peer-ReviewedBackground The combination of JAK/STAT and HDAC inhibitors exerted beneficial effects in haematological malignancies, presenting promising therapeutic CTCL targets. We aim to investigate the efficacy of JAK1/2i...
From:PLoS ONE (Vol. 12, Issue 1) Peer-ReviewedMycosis fungoides (MF) and its leukemic variant Sézary syndrome (SS) comprise the majority of CTCL, a heterogenous group of non-Hodgkins lymphomas involving the skin. The CTCL's resistance to chemotherapy and the...
From:Journal of Infectious Diseases (Vol. 215, Issue 5) Peer-ReviewedCitation Only
Choose how you want to be alerted when new results for your search become available.
Subscribe to Gale's RSS feed to get content delivered to your favorite RSS aggregator. Copy and paste the URL below into your reader:
Tell us where to send the alert and how often you want to receive it